YCBDNYSEPerfumes, Cosmetics & Other Toilet PreparationsUS GAAP · USD

cbdMD, Inc.

cbdMD, Inc. is a U.S.-based consumer products company that develops and sells hemp-derived wellness products under brands including cbdMD, Paw CBD, ATRx Labs, and Herbal Oasis. Its portfolio spans CBD tinctures, gummies, topicals, capsules, sleep and focus aids, functional mushroom products, and THC-infused beverages, sold through e-commerce, wholesale, and selected retail channels.

Kysy yhtiöstä
Liikevaihto19,2milj. USD
−1,5 %v/v
Liikevoitto (EBIT)−2,2milj. USD
+34,8 %v/v
EBIT-marginaali−11,3%
+5,7 %-yks.v/v
Nettotulos−2,0milj. USD
+44,8 %v/v
Vapaa kassavirta−1,6milj. USD
−201,5 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2020–2025

−100−75−50−2502550milj. USD2020: 42 milj. USD2020: EBIT −18 milj. USD20202021: 44 milj. USD2021: EBIT −20 milj. USD20212022: 35 milj. USD2022: EBIT −78 milj. USD20222023: 24 milj. USD2023: EBIT −22 milj. USD20232024: 19 milj. USD2024: EBIT −3,3 milj. USD20242025: 19 milj. USD2025: EBIT −2,2 milj. USD202519−2,2
LiikevaihtoLiikevoitto (EBIT)
Kysy Clarifolta: cbdMD, Inc.

Liiketoiminta

Osuus liikevaihdosta
CBD wellness products55 %

Broad-spectrum and full-spectrum hemp-derived CBD products for human use.

Pet wellness products10 %

CBD-based products sold under Paw CBD for pet health and wellness.

Functional mushroom and nootropic products10 %

ATRx Labs products focused on mushroom-based and cognitive wellness formulations.

THC beverages15 %

Herbal Oasis hemp-derived THC-infused ready-to-drink beverage products.

Wholesale and retail channel sales10 %

Sales through retail accounts, distributors, and other third-party channels.

Asiakkaat

cbdMD sells primarily to consumers buying directly online, as well as wholesale and retail partners that stock its branded hemp-derived products. Its customer base also includes pet owners, wellness-oriented shoppers, and channel partners such as specialty retailers, distributors, and beverage wholesalers.

Direct-to-consumer wellness shoppers

Buy CBD and wellness products online or by phone for convenience and brand selection.

Wholesale retail accounts

Retailers and specialty chains buy branded SKUs to sell through physical stores.

Distributors

Regional and category distributors buy products to expand market reach and placement.

Pet owners

Buy Paw CBD products for pet wellness and companion-animal use cases.

International consumers and partners

Buy through local wholesalers, legal partners, and e-commerce channels outside the U.S.

Strategia

cbdMD is focused on expanding its revenue channels across direct-to-consumer, wholesale, and retail distribution while broadening its brand portfolio. It is also building out newer growth platforms such as Herbal Oasis beverages and extending international sales through local partners and e-commerce.

Broaden distribution for Oasis and other brandsLyhyt aikaväli

More retail and distributor placements increase product availability and brand scale.

Improve direct-to-consumer marketing efficiencyLyhyt aikaväli

Online sales depend on cost-effective customer acquisition and repeat purchasing.

Build a multi-brand wellness platformKeskipitkä aikaväli

Multiple brands can broaden the addressable market and reduce reliance on one product line.

Expand internationally through compliant channelsKeskipitkä aikaväli

Foreign markets can add growth, but require local regulatory navigation.

Maantiede

cbdMD is headquartered in Charlotte, North Carolina and operates primarily in the United States. The company also sells into the United Kingdom through e-commerce and is pursuing additional international wholesale markets, especially in Central and South America.

Riskit

The business is exposed to regulatory scrutiny around hemp-derived cannabinoids, especially advertising and product claims, and to state-by-state packaging or labeling requirements. It also depends on efficient customer acquisition and continued acceptance of newer products, while wholesale and international expansion add execution and compliance complexity.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Regulatory enforcement on CBD and THC claims1Customer acquisition efficiency2Going concern / continued losses3State-level packaging and labeling changes4International regulatory complexity5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Regulatory enforcement on CBD and THC claimsVaikutus: KorkeaTodennäköisyys: Korkea

    The company markets hemp-derived wellness products that can attract FTC/FDA scrutiny.

    KohdistuuAdvertisingLabelingProduct claims
  2. Customer acquisition efficiencyVaikutus: KorkeaTodennäköisyys: Korkea

    Online sales rely on paid marketing and may become more expensive over time.

    Kohdistuu: E-commerce channel

  3. Going concern / continued lossesVaikutus: KorkeaTodennäköisyys: Korkea

    A history of operating losses can constrain investment and strategic flexibility.

    Kohdistuu: Corporate level

  4. State-level packaging and labeling changesVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Different jurisdictions may require reworks and reformulation of packaging materials.

    Kohdistuu: Wholesale and beverage distribution

  5. International regulatory complexityVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Foreign sales require local legal counsel and market-specific approvals.

    KohdistuuUKCentral AmericaSouth America
Kysy Clarifolta: cbdMD, Inc.

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition and returns reserve

Sales are point-in-time at shipment, but returns and allowances reduce net revenue.

Vaikutus: Affects reported net sales and comparability across periods

Inventory valuation

Inventory is subject to net realizable value adjustments and write-downs.

Vaikutus: Can materially affect cost of sales and gross margin

Advertising and marketing expense

Brand growth depends on paid marketing, which is expensed as incurred.

Vaikutus: Creates period-to-period volatility in operating expenses

Intangible assets and amortization

Acquired brands and other intangibles may require amortization and impairment testing.

Vaikutus: Can affect operating income and equity values

Lease accounting

Warehouse and office leases influence reported occupancy costs and liabilities.

Vaikutus: Affects operating expenses and balance sheet obligations

Samankaltaisia listattuja yhtiöitä

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Charlotte's Web Holdings, Inc.

CWBHF · Agricultural Production-Crops

CV Sciences, Inc.

CVSI · Pharmaceutical Preparations

Cannaisseur Group Inc.

TCRG · Medicinal Chemicals & Botanical Products

Target Group Inc.

CBDY · Medicinal Chemicals & Botanical Products

InMed Pharmaceuticals Inc.

INM · Pharmaceutical Preparations

CNBX Pharmaceuticals Inc.

CNBX · Pharmaceutical Preparations

Päivitetty: 24.9.2026

cbdMD, Inc. (YCBD) liikevaihto, tulos ja tunnusluvut 2025 – Clarifo